Handelsbanken Fonder’s Covetrus, Inc. Common Stock CVET Stock Holding History

Handelsbanken Fonder’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,600	Closed	-$347K	–	1642
2022 Q3	$347K	Hold	16,600	–	–	﹤0.01%	1162
2022 Q2	$344K	Hold	16,600	–	–	﹤0.01%	1255
2022 Q1	$279K	Sell	16,600 -4,100	-20%	-$71.7K	﹤0.01%	1545
2021 Q4	$413K	Hold	20,700	–	–	﹤0.01%	1478
2021 Q3	$375K	Hold	20,700	–	–	﹤0.01%	1513
2021 Q2	$559K	Buy	20,700 +3,100	+18%	+$86.7K	﹤0.01%	1300
2021 Q1	$527K	Hold	17,600	–	–	﹤0.01%	1172
2020 Q4	$506K	Hold	17,600	–	–	﹤0.01%	1151
2020 Q3	$429K	Hold	17,600	–	–	﹤0.01%	1066
2020 Q2	$315K	Buy	+17,600	New	+$231K	﹤0.01%	1193

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Handelsbanken Fonder's CVET Position: Q4 2022 in Review

Handelsbanken Fonder sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 16,600 shares — an estimated $347K sold.

Handelsbanken Fonder first reported a position in CVET in Q2 2020 and held it in 10 quarters. The position peaked at $559K in Q2 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Handelsbanken Fonder reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Handelsbanken Fonder sold 16,600 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $347K.
Handelsbanken Fonder first reported a position in Covetrus, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Handelsbanken Fonder's Covetrus, Inc. Common Stock position peaked at $559K in Q2 2021.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Handelsbanken Fonder's 13F filing for Q4 2022, filed 7 Feb 2023.